← Open Payments lookup

REGINA DIZON: Open Payments

NPI 1609538040 · NEWPORT BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,422 in 31 payments from 11 companies in 2025. Trend: 2023 $442 · 2024 $1,620 · 2025 $1,422

Food & beverage: $1,422
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.10$408
Alkermes, Inc.3$267
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$139
Neurocrine BioSciences, Inc.4$133
Supernus Pharmaceuticals, Inc.1$125
Axsome Therapeutics, Inc.1$124
E.R. Squibb & Sons, L.L.C.4$93
Indivior Inc.3$68
OWP Pharmaceuticals, Inc.1$23
Braeburn Inc.1$22

Products named: HETLIOZ, FANAPT, ARISTADA, CAPLYTA, INGREZZA, Qelbree, Auvelity, LYBALVI.

Industry payments across CA — which companies pay providers there.